UA95627C2 - Аминотиазолы и их применение - Google Patents

Аминотиазолы и их применение

Info

Publication number
UA95627C2
UA95627C2 UAA200811756A UAA200811756A UA95627C2 UA 95627 C2 UA95627 C2 UA 95627C2 UA A200811756 A UAA200811756 A UA A200811756A UA A200811756 A UAA200811756 A UA A200811756A UA 95627 C2 UA95627 C2 UA 95627C2
Authority
UA
Ukraine
Prior art keywords
aminothiazoles
amelioration
diseases
prevention
useful
Prior art date
Application number
UAA200811756A
Other languages
English (en)
Ukrainian (uk)
Inventor
Метью Дж. Ламарш
Саймон Бушель
Майкл А. Петейн
Льюїс Уайтхед
Original Assignee
Новартіс Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38645676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA95627(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Новартіс Аг filed Critical Новартіс Аг
Publication of UA95627C2 publication Critical patent/UA95627C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

В заявке описаны органические соединения, которые применимы для лечения, предупреждения и/или облегчения протекания заболеваний.
UAA200811756A 2006-05-31 2007-05-30 Аминотиазолы и их применение UA95627C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80969306P 2006-05-31 2006-05-31

Publications (1)

Publication Number Publication Date
UA95627C2 true UA95627C2 (ru) 2011-08-25

Family

ID=38645676

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200811756A UA95627C2 (ru) 2006-05-31 2007-05-30 Аминотиазолы и их применение

Country Status (32)

Country Link
US (2) US7851439B2 (ru)
EP (2) EP2044101B1 (ru)
JP (1) JP5351014B2 (ru)
KR (1) KR101061658B1 (ru)
CN (2) CN101454337A (ru)
AR (1) AR060977A1 (ru)
AU (1) AU2007255025B2 (ru)
BR (1) BRPI0711885A2 (ru)
CA (1) CA2650133A1 (ru)
CL (1) CL2007001542A1 (ru)
CR (1) CR10430A (ru)
DK (1) DK2044101T3 (ru)
EC (1) ECSP088922A (ru)
ES (1) ES2441993T3 (ru)
HK (1) HK1127614A1 (ru)
HR (1) HRP20140055T1 (ru)
IL (1) IL194880A (ru)
MA (1) MA30485B1 (ru)
MX (1) MX2008015216A (ru)
MY (1) MY146920A (ru)
NO (1) NO20085032L (ru)
NZ (1) NZ572154A (ru)
PE (2) PE20080103A1 (ru)
PL (1) PL2044101T3 (ru)
PT (1) PT2044101E (ru)
RU (1) RU2450015C2 (ru)
SI (1) SI2044101T1 (ru)
TN (1) TNSN08496A1 (ru)
TW (2) TWI342310B (ru)
UA (1) UA95627C2 (ru)
WO (1) WO2007142986A2 (ru)
ZA (1) ZA200808449B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR060977A1 (es) 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
KR20090082504A (ko) 2006-12-20 2009-07-30 노파르티스 아게 아미노티아졸 마크로사이클, 그의 항균 화합물로서의 용도 및 그의 제조 방법
TW200902540A (en) * 2007-06-04 2009-01-16 Novartis Ag Macrocycles and their uses
NZ585788A (en) * 2007-12-12 2011-07-29 Novartis Ag Aminothiazoles and their uses
AU2012261611B2 (en) * 2007-12-12 2014-05-15 Novartis Ag Aminothiazoles and their uses
WO2014167371A1 (en) * 2013-04-12 2014-10-16 Naicons S.C.A.R.L. Analogs of the antibiotic aminothiazole ge2270
CN106366168B (zh) * 2016-08-26 2020-09-15 上海交通大学 羊毛硫肽类抗菌肽及其脱氢衍生物的制备方法
CN107243008B (zh) * 2017-04-13 2021-03-30 中国科学院广州生物医药与健康研究院 吡唑并[1,5-a]吡啶类化合物的新应用及一种治疗脓肿分枝杆菌感染的组合物
CN113219078B (zh) * 2021-03-25 2022-12-16 广东产品质量监督检验研究院（国家质量技术监督局广州电气安全检验所、广东省试验认证研究院、华安实验室） 一种生活用纸制品中17种有机抗菌剂快速筛查方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202241A (en) 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
EP0406745B1 (en) 1989-07-04 1995-01-25 GRUPPO LEPETIT S.p.A. Antibiotic GE 2270 factors A1, A2, A3 and H
DE69108972T2 (de) 1990-03-08 1995-10-19 Lepetit Spa Antibiotika GE 2270 Faktoren B1, B2, C1, D1, D2, E und T.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
EP0529410B1 (en) 1991-08-30 1998-02-25 Biosearch Italia S.p.A. Antibiotic GE 2270 factor C2a
US5882900A (en) 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
WO1994014838A1 (en) 1992-12-22 1994-07-07 Gruppo Lepetit S.P.A. Antibiotics ge 37468 a, b and c
WO1996014427A1 (en) * 1994-11-08 1996-05-17 Gruppo Lepetit S.P.A. Microbial transformation process for obtaining antibiotic ge 2270 factor d¿2?
WO1996024608A1 (en) 1995-02-07 1996-08-15 Biosearch Italia S.P.A. Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
EP0801655B1 (en) 1995-02-07 1998-04-15 Biosearch Italia S.p.A. Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
AU714958B2 (en) * 1996-02-14 2000-01-13 Vicuron Pharmaceuticals Inc. Derivatives of antibiotic GE2270 factors C2a D2 and E
JPH1059997A (ja) * 1996-08-22 1998-03-03 Microbial Chem Res Found アミチアマイシンアミド誘導体
WO2003105881A1 (en) * 2002-06-17 2003-12-24 Vicuron Pharmaceuticals Inc. Use of amide derivative of ge 2270 factor a3 for the treatment of acne
CN101198318A (zh) 2004-09-22 2008-06-11 默克公司 抗生素化合物
AR060977A1 (es) 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
NZ585788A (en) * 2007-12-12 2011-07-29 Novartis Ag Aminothiazoles and their uses

Also Published As

Publication number Publication date
HRP20140055T1 (hr) 2014-02-14
US20100267757A1 (en) 2010-10-21
MY146920A (en) 2012-10-15
SI2044101T1 (sl) 2014-01-31
WO2007142986A3 (en) 2008-04-10
JP5351014B2 (ja) 2013-11-27
AU2007255025A1 (en) 2007-12-13
IL194880A (en) 2015-02-26
ECSP088922A (es) 2008-12-30
WO2007142986A2 (en) 2007-12-13
EP2044101A2 (en) 2009-04-08
DK2044101T3 (da) 2014-01-13
TW201107337A (en) 2011-03-01
EP2322536A3 (en) 2011-11-30
PL2044101T3 (pl) 2014-03-31
HK1127614A1 (en) 2009-10-02
ES2441993T3 (es) 2014-02-07
KR101061658B1 (ko) 2011-09-01
MA30485B1 (fr) 2009-06-01
CN102399260B (zh) 2015-04-15
TWI342310B (en) 2011-05-21
EP2322536A2 (en) 2011-05-18
PE20121011A1 (es) 2012-08-25
AU2007255025B2 (en) 2011-07-14
PE20080103A1 (es) 2008-04-03
CN101454337A (zh) 2009-06-10
ZA200808449B (en) 2014-12-23
RU2450015C2 (ru) 2012-05-10
CL2007001542A1 (es) 2008-03-14
AR060977A1 (es) 2008-07-23
NZ572154A (en) 2011-12-22
US7851439B2 (en) 2010-12-14
US20080221142A1 (en) 2008-09-11
CR10430A (es) 2009-01-15
BRPI0711885A2 (pt) 2012-03-06
JP2009538914A (ja) 2009-11-12
MX2008015216A (es) 2008-12-12
EP2044101B1 (en) 2013-10-09
TW200811189A (en) 2008-03-01
KR20090006869A (ko) 2009-01-15
PT2044101E (pt) 2014-01-03
CA2650133A1 (en) 2007-12-13
CN102399260A (zh) 2012-04-04
NO20085032L (no) 2008-12-16
IL194880A0 (en) 2011-08-01
TNSN08496A1 (en) 2010-04-14
RU2008150785A (ru) 2010-07-10

Similar Documents

Publication Publication Date Title
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
TNSN08400A1 (en) Organic compounds and their uses
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
TN2011000482A1 (en) Organic compounds and their uses
TNSN08496A1 (en) Aminothiazoles and their uses
WO2007121125A3 (en) Hcv inhibitors
JO3235B1 (ar) مركبات بيررولوبيريميدين و استعمالاتها
WO2007095638A3 (en) Boron-containing small molecules as anti-inflammatory agents
IL233634A0 (en) Methods, compositions and kits for treating medical conditions
EA200900798A1 (ru) Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
SG170813A1 (en) New compounds
MX2009004047A (es) Compuestos organicos.
WO2008067219A3 (en) Quinazolinone modulators of tgr5
WO2007121124A3 (en) Hcv inhibitors comprising beta amino acids and their uses
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
WO2010037095A3 (en) Agents and methods for the treatment of cancer
WO2008033389A3 (en) Macrocyclic hcv inhibitors and their uses
TN2009000495A1 (en) Macrocycles and their uses
WO2007115287A3 (en) Combination of organic compounds
WO2007064997A3 (en) Compounds and methods for inhibiting apoptosis
WO2008103431A3 (en) Dnai - liposomes
WO2008085927A3 (en) Methods, compositions, and kits for the treatment of pain
AP2005003270A0 (en) Composition for the treatment of humans.